Specialty Pharmacy

Using data and bioinformatics could hold the key to numerous treatment options.

Anti-tumor necrotic factor drugs could help delay hip deterioration in patients with ankylosing spondylitis.

Research evaluates sofosbuvir use in hepatitis C patients with a mental health disease.

Patients who live with rheumatoid arthritis do not die from swollen joints but face twice the risk of suffering a heart attack or stroke.

Telehealth broadly is about creating care connections across boundaries, care that encourages patients’ independence, prevention and wellness; and care that can be leveraged for needed interventions. If we get telehealth right we can reduce impact of what we know is a growing health workforce shortage and concurrently create a healthier, more engaged patient base.

The 12-biomarker test is gaining acceptance among rheumatologists and was recently added to a clinical guideline.

Be careful what you wish for: SGR and FFS will be models of the past; the success of the APM and MIPS will rely on compensation, collaboration and participation; and, to date, much remains to be done in the development of quality-based payment reform under MACRA.

New therapeutic targets provide hope for targeted treatments for rheumatoid diseases.

JAK inhibitors may be more effective than older biologic drugs in certain patients.

New data from studies of multiple drugs highlights Janssen’s commitment to rheumatic diseases.

Pfizer will highlight successes of Xeljanz at ACR/ARHP annual meeting.

A 2-year study will examine the effectiveness of advanced MRI to determine response to breast cancer treatment.

A recent review outlines the best treatment option to prevent bone loss associated with rheumatoid arthritis.

Vietnam War veterans are more likely to contract hepatitis C virus than any other veterans, and 65-year-old Joe Benko was no exception to the statistic.

Top articles of the week on Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Long-term oxygen treatment did not improve survival in patients with COPD with moderately low blood oxygen levels.

Tenofovir-alafenamide combination approved by the FDA for chronic hepatitis B infection.

Researchers develop a USB device that can detect HIV with 95% accuracy.

Amgen will present findings from clinical studies of both branded and investigational drugs.

Accreditation provides value for specialty pharmacy patients and stakeholders.

Patients with MS show damage to the pyramidal system had diminished posture control.

Multiple sclerosis may not be associated with developing breast cancer in pre- and postmenopausal women, according to a recent study.

Top news of the day from across the healthcare landscape.

Rituximab is a cancer medication that can be used in combination with methotrexate to treat symptoms of adult rheumatoid arthritis.

In a recent study, investigators found that the application of a topical gel that contains the gene heat shock protein 60 significantly increased wound healing in a mouse model of diabetes.

A majority of specialty physicians have knowledge gaps when it comes to biosimilars.

Beneficial results seen when switching to a HIV regimen including Odefsey.

Recent findings suggest that calcium may play a role in the switch from acute to chronic lung infection from the bacterium Pseudomonas aeruginosa.

Interfering with energetic metabolism may stop glioblastoma growth and recurrence.